Stay updated on Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.

Latest updates to the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows a revision from v3.4.1 to v3.4.2, representing a small metadata update with no substantive changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedSite revision updated from v3.4.0 to v3.4.1; no observable changes to study details or user-facing content.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4; the study details and other content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded a Locations section listing North Carolina, Texas, and Virginia; updated the page revision to v3.3.3.SummaryDifference0.4%

- Check91 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.2, a minor maintenance change with no substantive study content altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedRemoved the banner about government funding lapse and operating status; no study data or links were changed.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.